Skip to content

AtriCure

US · ATRC #2543 by market cap Listed 1970
55.39 +1.28 +2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About AtriCure

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Founded
2000
CEO
Mr. David J. Drachman
Employees
1,350
Headquarters
Mason, Ohio, United States of America
Fiscal year end
12-31
Website
atricure.com

Company profile

Exchange
US
Symbol
ATRC
Market-cap rank
#2543
Listing date
1970-01-01
Market cap
2.82B
Float cap
2.71B
Shares out
50.92M
Float shares
48.88M

Sectors & themes

Medical Instruments & Supplies Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AtriCure discussion 0 comments

Add a comment